Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer

PACIFIC Investigators

Research output: Contribution to journalArticlepeer-review

2240 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences